Loading, please wait...
.webp&w=384&q=75){kind=logo}
Verifying...
Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
Hippocrates
Gautam Adani recently launched a landmark vision care in Bihar initiative to address rural health challenges. This ambitious project focuses on providing affordable treatment and building a sustainable healthcare ecosystem in the region. Consequently, the Adani Akhand Jyoti Foundation seeks to restore sight and dignity to underserved communities. Furthermore, the initiative targets the completion of 3.3 lakh eye surgeries annually. This effort will significantly reduce the burden of preventable blindness in the Hindi heartland.
The project establishes two primary facilities: the Adani Centre for Eye (ACE) and Adani Training in Ophthalmic Medicine (ATOM). Specifically, ACE handles complex surgical procedures and advanced treatments. Meanwhile, ATOM focuses on essential workforce development. It will train 1,000 eye health professionals, including optometrists and assistants, every year. Moreover, this dual approach ensures that infrastructure growth matches the availability of skilled personnel. Additionally, the group plans to establish a 200-bed hospital in the Bhagalpur district to serve eastern Bihar.
The Adani family has committed significant resources to this long-term mission. Initially, the project received Rs 150 crore for immediate development in Bihar. However, Gautam Adani later announced an additional personal commitment of Rs 500 crore to scale the mission nationwide. Consequently, the total investment outlay will exceed Rs 700 crore. This investment reflects a broader vision of nation-building through social service and healthcare excellence. Similarly, the foundation continues to support various rural outreach programs across eleven states in India.
Q1: What is the primary goal of the Adani Centre for Eye (ACE)?
ACE aims to provide advanced treatment and surgical facilities focused on affordable care and large-scale rural outreach in Bihar.
Q2: How many eye health professionals will be trained annually?
The initiative plans to train 1,000 eye health professionals every year through the Adani Training in Ophthalmic Medicine (ATOM) facility.
Q3: What is the total investment commitment for this vision care project?
The total investment outlay, including operational expenditure, is expected to exceed Rs 700 crore across its expansion phases.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Link will be sent via SMS to your number.
Gautam Adani initiates a Rs 150 crore vision care project in Bihar to provide affordable eye surgeries and train 1,000 healthcare professionals annually....
last month
A recent study demonstrates that Roflumilast, a PDE4 inhibitor, provides a significant renoprotective effect against amikacin-induced nephrotoxicity by upregulating Nrf2 signaling and suppressing inflammatory and apoptotic pathways.
Today
A study on 294 women after the Kahramanmaras earthquake shows that death distress, especially death depression, significantly influences fertility intentions. Key factors include age, income, and trauma experience, highlighting the need for mental health support in post-disaster care.
Today
Recent research highlights mussel-inspired catechol-amine copolyether brushes as a breakthrough in antifouling. By achieving high grafting density and maintaining chemical integrity, these coatings effectively prevent biofilm formation on medical devices, offering a substrate-independent solution for clinicians.
Today
A randomized controlled trial compared static stretching and myofascial release for hamstring tightness in IT professionals. While both methods improved flexibility, myofascial release demonstrated superior results in range of motion and functional scores over a three-week treatment period.
Today
Recent research identifies miR-335-5p as a key regulator for redifferentiating BRAF-mutant thyroid cancers. Restoring this microRNA enhances iodine uptake and inhibits EMT pathways, potentially resensitizing tumors to radioiodine and improving kinase inhibitor outcomes for refractory patients.
Today